Excellence in Scientific Discovery
The Institute's comprehensive investigations extend from the earliest phase of basic discovery to the development of new cancer diagnostics, treatment protocols and prevention strategies
Basic, clinical and translational studies into the biology of cancer and the factors that contribute to its onset and growth.
The most sophisticated technologies and research protocols are offered to SCI members through a number of core facilities.
Inter-disciplinary teams of collaborative investigators partner to foster discovery, application and translation of scientific knowledge.
Scientists and physicians from a wide range of disciplines, all dedicated to reducing the burden of cancer.
Publications, press releases and news are shared with scientists, physicians, patients and friends of the Institute.
Internal and external sources of support for both established cancer research programs and promising new ideas.
The Cancer Clinical Trials Office provides regulatory and administrative services to SCI members conducting clinical trials.
Education and professional development designed to train the next generation of cancer researchers and physicians.
National Cancer Institute Designation
In addition to providing grants and other support to cancer researchers at institutions around the country, the National Cancer Institute employs scientists who conduct basic, clinical, and population-based research, including the study of rare cancers and the translation of laboratory findings to the clinic.
More about our NCI Designation
Sanjiv Sam Gambhir dies at 57
The professor and chair of radiology at Stanford was a global leader in advancing techniques for molecular imaging and early cancer detection.
Cancer experience drives scientific curiosity
New Stanford graduate Nico Poux, a former pediatric oncology patient at Lucile Packard Children’s Hospital Stanford, hopes to bring his experience with cancer to future work as a physician-scientist.
Subset of cells drive cancer growth
Specialized cells at the leading edge of growing skin cancers dampen immune response and promote cancer invasion, Stanford researchers find. Targeting these cells could lead to effective therapies.